Table 5.
Correlation between miR-215 expression levels and age, some laboratory data in addition to some clinicopathologic findings within HCC group
| Group III | miR-215 | |
|---|---|---|
| r | P-values | |
| Age (years) | 0.129 | 0.285 |
| WBCs (×103/μL) | –0.018 | 0.885 |
| Hb (g/dL) | –0.141 | 0.244 |
| Platelets (×103/μL) | –0.138 | 0.256 |
| ALT (U/L) | 0.117 | 0.334 |
| AST (U/L) | 0.087 | 0.476 |
| Total bilirubin (mg/dL) | 0.287 | 0.016a |
| Direct bilirubin (mg/dL) | 0.307 | 0.010a |
| ALB (g/dL) | –0.025 | 0.836 |
| INR | 0.065 | 0.594 |
| Tumor sizeb | 0.527 | <0.001a |
| PVTb | 0.554 | <0.001a |
Notes:Pearson’s correlation coefficient.
a
Significant correlation at P-value ≤0.05.
b
Spearman’s correlation coefficient. r=0.75–1 (strong correlation), r=0.5–0.74 (moderate correlation), r=0.25–0.49 (fair correlation), and r=0.1–0.24 (weak correlation). Bold data indicates r with P-values Significant (P-value≤0.05).
Abbreviations: ALB, albumin; ALT, alanine aminotransferase; AST, aspartate aminotransferase; Hb, hemoglobin; HCC, hepatocellular carcinoma; INR, international normalized ratio; WBC, white blood cell.